Lindsay Anne (Magura) Rein MD
Myeloproliferative Disorder Hematology-Oncology
Physician
Join to View Full Profile
40 Duke Medicine CirDurham, NC 27710
Phone+1 919-684-8111
Dr. Rein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014- Duke University HospitalResidency, Internal Medicine, 2008 - 2011
University of North Dakota School of Medicine and Health SciencesClass of 2008
Certifications & Licensure
NC State Medical License 2008 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms.Jill Brennan-Cook, Lindsay Rein, Andrew Kuykendall, Natasha Johnson, Amie Koch
Journal of Palliative Medicine. 2025-02-01 - 2 citationsNCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, Haris Ali, Mariana Castells
Journal of the National Comprehensive Cancer Network. 2024-06-01 - 15 citationsAvapritinib versus Placebo in Indolent Systemic Mastocytosis.Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann
NEJM Evidence. 2023-06-01
Press Mentions
SUMMIT Results: Bezuclastinib in Non-Advanced Systemic MastocytosisApril 3rd, 2025- What's Your Approach? Treating MyelofibrosisAugust 7th, 2024
OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesApril 25th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
